2022
DOI: 10.1021/acs.biochem.1c00796
|View full text |Cite
|
Sign up to set email alerts
|

Conformation-Dependent Reversible Interaction of Ca2+/Calmodulin-Dependent Protein Kinase Kinase with an Inhibitor, TIM-063

Abstract: Ca2+/calmodulin-dependent protein kinase kinase (CaMKK), a Ca2+/CaM-dependent enzyme that phosphorylates and activates multifunctional kinases, including CaMKI, CaMKIV, protein kinase B/Akt, and 5′AMP-activated protein kinase, is involved in various Ca2+-signaling pathways in cells. Recently, we developed an ATP-competitive CaMKK inhibitor, TIM-063 (2-hydroxy-3-nitro-7H-benzo­[de]­benzo­[4,5]­imidazo­[2,1-a]­isoquinolin-7-one, Ohtsuka et al. Biochemistry 2020, 59, 1701–1710). To gain mechanistic insights into … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(8 citation statements)
references
References 35 publications
1
7
0
Order By: Relevance
“…1 a). Consistent with results of a previous report 12 , CaMKKα/1 and β/2 were readily identified as the main targets of TIM-063 and two potential off-target protein kinases, AAK1 and ERK2, were detected by the proteomic approach (Table 1 and Supplemental Information S1 ). This was confirmed by immunoblot analyses with the corresponding antibodies, indicating that the protein kinases interacted with the TIM-063 motif on the inhibitor-immobilized sepharose but not with the control sepharose (Fig.…”
Section: Resultssupporting
confidence: 90%
See 3 more Smart Citations
“…1 a). Consistent with results of a previous report 12 , CaMKKα/1 and β/2 were readily identified as the main targets of TIM-063 and two potential off-target protein kinases, AAK1 and ERK2, were detected by the proteomic approach (Table 1 and Supplemental Information S1 ). This was confirmed by immunoblot analyses with the corresponding antibodies, indicating that the protein kinases interacted with the TIM-063 motif on the inhibitor-immobilized sepharose but not with the control sepharose (Fig.…”
Section: Resultssupporting
confidence: 90%
“…TIM-063 (2-hydroxy-3-nitro-7 H -benzo[de]benzo[4, 5]-imidazo[2,1- a ]isoquinolin-7-one, Fig. 1 a) was originally developed as a CaMKK inhibitor via screening of an STO-609–derived chemical library 11 and TIM-063–immobilized sepharose (TIM-127-sepharose) was used to characterize the Ca 2+ /CaM-dependent interaction of CaMKK and the inhibitor 12 . Because TIM-063 is an ATP-competitive inhibitor similar to STO-609 31 , the inhibitor may interact and inhibit off-target kinases.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The inhibitory properties of TIM-063 are similar to STO-609, except that TIM-063 can similarly inhibit both CaMKKα/1 (0.63 µM) and β/2 (0.96 µM). Moreover, TIM-063 has been shown to interact with and inhibit CaMKK in its active state (Ca 2+ /CaM-bound form) but not in its autoinhibited state (Ca 2+ /CaM-unbound form); this interaction is likely reversible, depending on the intracellular Ca 2+ concentration [ 130 ]. TIM-063, but not TIM-062, suppresses the Ca 2+ -induced phosphorylation of AMPK, CaMKI, and CaMKIV in cultured cells.…”
Section: Camkk Inhibitors and Pharmacological Analyses Of Signaling P...mentioning
confidence: 99%